# Avenue Biosciences Holding Inc — Form D

Avenue Biosciences Holding Inc of MENLO PARK, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-01-28. The offering totals $8.4M, of which $7.4M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2026-01-28
- Form: D
- Accession: 0002101752-26-000001
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $8.4M
- Amount sold: $7.4M
- Remaining: $917K
- Investors: 12
- Date of first sale: 2025-11-20
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-571363

## Issuer

- Name: Avenue Biosciences Holding Inc
- CIK: 0002101752
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 211 LAUREL STREET, MENLO PARK, CA, 94025
- Phone: 6502858564

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Tero-Pekka Alastalo | Director | Menlo Park, CA |
| Jenny Engerfelt | Director | Borensberg, V7 |
| Gabriel Poteliunaite | Director | Gdansk, R9 |
| Katja Rosti | Director | Helsinki, H9 |
| Tero-Pekka Alastalo | Executive Officer | Menlo Park, CA |
| Katja Rosti | Executive Officer | Helsinki, H9 |

## More

- [CIK 2101752 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2101752&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002101752-26-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.